US Stock MarketDetailed Quotes

MBX Biosciences (MBX)

Watchlist
  • 35.360
  • -2.140-5.71%
Close May 14 16:00 ET
  • 35.800
  • +0.440+1.24%
Post 20:01 ET
1.68BMarket Cap-16.29P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

MBX Biosciences (MBX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
10.89%-20.21M
-46.21%-79.95M
-14.12%-18.3M
-46.86%-21.54M
-31.38%-17.43M
-111.75%-22.68M
-71.00%-54.68M
-43.88%-16.04M
-89.80%-14.66M
-13.27M
Net income from continuing operations
1.52%-23.52M
-40.45%-86.97M
-41.55%-22.06M
-19.16%-21.62M
-22.41%-19.41M
-93.56%-23.88M
-90.16%-61.92M
-76.25%-15.59M
-78.51%-18.14M
---15.86M
Depreciation and amortization
-16.88%64K
1.64%248K
3.45%60K
-33.33%50K
-3.17%61K
60.42%77K
55.41%244K
41.46%58K
87.50%75K
--63K
Other non cash items
17.24%34K
25.47%133K
18.52%32K
18.52%32K
48.15%40K
16.00%29K
11.58%106K
8.00%27K
12.50%27K
--27K
Change In working capital
-382.33%-1.69M
-65.74%1.58M
350.08%1.57M
-154.53%-1.51M
-54.53%918K
38.25%600K
725.44%4.6M
78.05%-627K
54.63%2.77M
--2.02M
-Change in prepaid assets
-143.99%-725K
-14.86%-2.7M
-94.85%-2.01M
-171.53%-1.55M
31.35%-795K
303.92%1.65M
-124.26%-2.35M
22.16%-1.03M
-562.60%-569K
---1.16M
-Change in payables and accrued expense
12.03%-885K
-38.86%4.34M
712.67%3.59M
-100.12%-4K
-45.32%1.76M
-1,696.83%-1.01M
1,453.17%7.1M
129.64%442K
98.24%3.38M
--3.22M
-Change in other current assets
---43K
---493K
--8K
--65K
---566K
--0
--0
--0
--0
----
-Change in other current liabilities
2.38%-41K
377.78%425K
32.50%-27K
28.95%-27K
1,471.05%521K
-13.51%-42K
-11.68%-153K
-14.29%-40K
-8.57%-38K
---38K
Cash from discontinued investing activities
Operating cash flow
10.89%-20.21M
-46.21%-79.95M
-14.12%-18.3M
-46.86%-21.54M
-31.38%-17.43M
-111.75%-22.68M
-71.00%-54.68M
-43.88%-16.04M
-89.80%-14.66M
---13.27M
Investing cash flow
Cash flow from continuing investing activities
-3,109.83%-97.1M
47.88%-83.71M
-93.00%-129.97M
116.92%17.06M
429.31%25.99M
-79.09%3.23M
-419.27%-160.6M
-132.59%-67.35M
-441.73%-100.79M
-7.89M
Net PPE purchase and sale
-1,356.67%-437K
-120.71%-1.93M
-761.96%-793K
-600.00%-399K
-56.42%-707K
89.01%-30K
-577.52%-874K
-67.27%-92K
-159.09%-57K
---452K
Net investment purchase and sale
-3,068.67%-96.66M
48.80%-81.78M
-92.08%-129.18M
117.33%17.46M
458.83%26.69M
-79.26%3.26M
-418.61%-159.72M
-132.71%-67.25M
-442.06%-100.73M
---7.44M
Cash from discontinued investing activities
Investing cash flow
-3,109.83%-97.1M
47.88%-83.71M
-93.00%-129.97M
116.92%17.06M
429.31%25.99M
-79.09%3.23M
-419.27%-160.6M
-132.59%-67.35M
-441.73%-100.79M
---7.89M
Financing cash flow
Cash flow from continuing financing activities
2,185,775.00%87.44M
-19.01%189.59M
431.82%438K
-20.35%187.82M
175.30%1.33M
-97.81%4K
238.21%234.1M
-794.74%-132K
244.27%235.81M
-1.76M
Net common stock issuance
--85.37M
7.68%187.95M
--0
----
----
--0
--174.54M
--0
----
----
Net preferred stock issuance
----
--0
--0
----
----
----
-7.31%63.5M
--0
----
----
Proceeds from stock option exercised by employees
60,950.00%2.44M
499.26%2.42M
389.74%955K
519.35%130K
2,552.00%1.33M
-97.88%4K
-45.47%403K
926.32%195K
-282.35%-31K
--50K
Net other financing activities
---378K
82.24%-771K
-58.10%-517K
----
----
----
-14,370.00%-4.34M
---327K
---2.2M
---1.81M
Cash from discontinued financing activities
Financing cash flow
2,185,775.00%87.44M
-19.01%189.59M
431.82%438K
-20.35%187.82M
175.30%1.33M
-97.81%4K
238.21%234.1M
-794.74%-132K
244.27%235.81M
---1.76M
Net cash flow
Beginning cash position
52.56%75.29M
61.68%49.35M
67.93%223.13M
218.17%39.78M
-15.59%29.9M
61.68%49.35M
26.08%30.52M
88.18%132.87M
-56.04%12.5M
--35.43M
Current changes in cash
-53.59%-29.87M
37.76%25.94M
-77.02%-147.84M
52.33%183.34M
143.09%9.88M
-496.74%-19.45M
198.24%18.83M
-108.36%-83.51M
185.45%120.36M
---22.92M
End cash Position
51.89%45.42M
52.56%75.29M
52.56%75.29M
67.93%223.13M
218.17%39.78M
-15.59%29.9M
61.68%49.35M
61.68%49.35M
88.18%132.87M
--12.5M
Free cash flow
9.08%-20.65M
-47.38%-81.88M
-18.38%-19.09M
-49.00%-21.94M
-32.20%-18.14M
-106.76%-22.71M
-73.03%-55.56M
-44.00%-16.13M
-90.00%-14.72M
---13.72M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 10.89%-20.21M-46.21%-79.95M-14.12%-18.3M-46.86%-21.54M-31.38%-17.43M-111.75%-22.68M-71.00%-54.68M-43.88%-16.04M-89.80%-14.66M-13.27M
Net income from continuing operations 1.52%-23.52M-40.45%-86.97M-41.55%-22.06M-19.16%-21.62M-22.41%-19.41M-93.56%-23.88M-90.16%-61.92M-76.25%-15.59M-78.51%-18.14M---15.86M
Depreciation and amortization -16.88%64K1.64%248K3.45%60K-33.33%50K-3.17%61K60.42%77K55.41%244K41.46%58K87.50%75K--63K
Other non cash items 17.24%34K25.47%133K18.52%32K18.52%32K48.15%40K16.00%29K11.58%106K8.00%27K12.50%27K--27K
Change In working capital -382.33%-1.69M-65.74%1.58M350.08%1.57M-154.53%-1.51M-54.53%918K38.25%600K725.44%4.6M78.05%-627K54.63%2.77M--2.02M
-Change in prepaid assets -143.99%-725K-14.86%-2.7M-94.85%-2.01M-171.53%-1.55M31.35%-795K303.92%1.65M-124.26%-2.35M22.16%-1.03M-562.60%-569K---1.16M
-Change in payables and accrued expense 12.03%-885K-38.86%4.34M712.67%3.59M-100.12%-4K-45.32%1.76M-1,696.83%-1.01M1,453.17%7.1M129.64%442K98.24%3.38M--3.22M
-Change in other current assets ---43K---493K--8K--65K---566K--0--0--0--0----
-Change in other current liabilities 2.38%-41K377.78%425K32.50%-27K28.95%-27K1,471.05%521K-13.51%-42K-11.68%-153K-14.29%-40K-8.57%-38K---38K
Cash from discontinued investing activities
Operating cash flow 10.89%-20.21M-46.21%-79.95M-14.12%-18.3M-46.86%-21.54M-31.38%-17.43M-111.75%-22.68M-71.00%-54.68M-43.88%-16.04M-89.80%-14.66M---13.27M
Investing cash flow
Cash flow from continuing investing activities -3,109.83%-97.1M47.88%-83.71M-93.00%-129.97M116.92%17.06M429.31%25.99M-79.09%3.23M-419.27%-160.6M-132.59%-67.35M-441.73%-100.79M-7.89M
Net PPE purchase and sale -1,356.67%-437K-120.71%-1.93M-761.96%-793K-600.00%-399K-56.42%-707K89.01%-30K-577.52%-874K-67.27%-92K-159.09%-57K---452K
Net investment purchase and sale -3,068.67%-96.66M48.80%-81.78M-92.08%-129.18M117.33%17.46M458.83%26.69M-79.26%3.26M-418.61%-159.72M-132.71%-67.25M-442.06%-100.73M---7.44M
Cash from discontinued investing activities
Investing cash flow -3,109.83%-97.1M47.88%-83.71M-93.00%-129.97M116.92%17.06M429.31%25.99M-79.09%3.23M-419.27%-160.6M-132.59%-67.35M-441.73%-100.79M---7.89M
Financing cash flow
Cash flow from continuing financing activities 2,185,775.00%87.44M-19.01%189.59M431.82%438K-20.35%187.82M175.30%1.33M-97.81%4K238.21%234.1M-794.74%-132K244.27%235.81M-1.76M
Net common stock issuance --85.37M7.68%187.95M--0----------0--174.54M--0--------
Net preferred stock issuance ------0--0-------------7.31%63.5M--0--------
Proceeds from stock option exercised by employees 60,950.00%2.44M499.26%2.42M389.74%955K519.35%130K2,552.00%1.33M-97.88%4K-45.47%403K926.32%195K-282.35%-31K--50K
Net other financing activities ---378K82.24%-771K-58.10%-517K-------------14,370.00%-4.34M---327K---2.2M---1.81M
Cash from discontinued financing activities
Financing cash flow 2,185,775.00%87.44M-19.01%189.59M431.82%438K-20.35%187.82M175.30%1.33M-97.81%4K238.21%234.1M-794.74%-132K244.27%235.81M---1.76M
Net cash flow
Beginning cash position 52.56%75.29M61.68%49.35M67.93%223.13M218.17%39.78M-15.59%29.9M61.68%49.35M26.08%30.52M88.18%132.87M-56.04%12.5M--35.43M
Current changes in cash -53.59%-29.87M37.76%25.94M-77.02%-147.84M52.33%183.34M143.09%9.88M-496.74%-19.45M198.24%18.83M-108.36%-83.51M185.45%120.36M---22.92M
End cash Position 51.89%45.42M52.56%75.29M52.56%75.29M67.93%223.13M218.17%39.78M-15.59%29.9M61.68%49.35M61.68%49.35M88.18%132.87M--12.5M
Free cash flow 9.08%-20.65M-47.38%-81.88M-18.38%-19.09M-49.00%-21.94M-32.20%-18.14M-106.76%-22.71M-73.03%-55.56M-44.00%-16.13M-90.00%-14.72M---13.72M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.75%
Sample Name
Sample Code
 +15.52%
Sample Name
Sample Code
 +14.53%
4
United States Oil Fund LP
USO
+13.64%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.14%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.99%
Sample Name
Sample Code
 +9.49%
Sample Name
Sample Code
 +8.77%
4
Hesai
HSAI
+8.01%
5
NIO Inc
NIO
+6.47%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -